top of page
Search

2027 Funding Opportunities for Health Projects under Horizon Europe

Oct 6
2 min read

Updated: Oct 26

Discover the 2027 funding opportunitiesin health and cancer mission


The 2027 Horizon Europe Health Work Programme includes calls addressing healthy ageing and inclusion, climate-related health challenges, infectious and non-communicable diseases, digital health and new technologies, and the competitiveness of the EU health industry.


Key Dates

10 February 2027

Most Health Funding calls open

13 April 2027

Deadline Stage 1

22 September 2027

Deadline Stage 2

2027 Horizon Europe Health Calls

  • Disabilities - HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion

  • Climate - HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposures and characterising its changes in response to climate change

  • Climate change - HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change

  • Antiviral therapeutics - HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential

  • Monoclonal antibodies - HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

  • Monoclonal antibodies - HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenu-, Picorna- and Toga viruses

  • Antimicrobials - HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials

  • Chronic non-communicable diseases - HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)

  • Non-communicable diseases - HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases

  • Neurodegenerative diseases - HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseases

  • Adverse Drug Reactions - HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

  • Regenerative medicine - HORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicine

  • Virtual Human Twins (VHTs) - HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis

  • Artificial Intelligence - HORIZON-HLTH-2027-03-TOOL-08: Towards Artificial General Intelligence (AGI) for healthcare

  • Chronic non-communicable diseases - HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

  • Cell-free protein - HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals

  • Point-of-care diagnostics - HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics

  • Cancer - HORIZON-MISS-2027-02-CANCER-01: Leveraging functional genomics to reveal novel targets for cancer treatment

  • Cancer - HORIZON-MISS-2027-02-CANCER-02: Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

  • Cancer - HORIZON-MISS-2027-02-CANCER-03: Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multimodal treatment interventions for patients with rare or very rare cancers or cancer subtypes

  • Cancer - HORIZON-MISS-2027-02-CANCER-04: Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research

  • Cancer - HORIZON-MISS-2027-02-CANCER-05: Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines

  • Cancer - HORIZON-MISS-2027-02-CANCER-06: Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies


For more information about the call budget, type of project, expected project budget, expected number of projects and deadline, please refer to the full document.



Could your project fit one of these calls?

France Europe Innovation can support you in identifying relevant Horizon Europe opportunities, assessing project fit, building consortia and preparing competitive proposals.




 
 
 

Comments


bottom of page